Gilead Sciences, Inc. (LON:0QYQ)
London · Delayed Price · Currency is GBP · Price in USD 120.63
+1.02 (0.86%)
At close: Dec 15, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of 111.05 billion as of December 15, 2025. Its market cap has increased by 22.13% in one year.
Market Cap
111.05B
Enterprise Value
121.78B
Revenue
21.64B
Ranking
n/a
PE Ratio
18.41
Stock Price
120.63
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 111.05B, an increase of 79,946.60%. That is a compound annual growth rate of 21.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 111.05B | 20.77% |
| Dec 31, 2024 | 91.95B | 16.03% |
| Dec 29, 2023 | 79.25B | -11.32% |
| Dec 30, 2022 | 89.37B | 32.86% |
| Dec 31, 2021 | 67.26B | 25.75% |
| Dec 31, 2020 | 53.49B | -13.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.48B |
| HSBC Holdings | 192.86B |
| Shell | 154.81B |
| Unilever | 107.22B |
| Rio Tinto Group | 96.41B |
| Rolls-Royce Holdings | 93.25B |
| British American Tobacco p.l.c. | 92.16B |
| GSK plc | 73.26B |